Figure 4From: Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI) Assessments of improvement and satisfaction. (a) Physicians’ rating of improvement during moxifloxacin therapy; (b) patients’ satisfaction with moxifloxacin therapy (efficacy population).Back to article page